APLS
Apellis Pharmaceuticals, Inc.NASDAQHealthcare$40.41+0.54%ClosedMarket Cap: $5.17B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
28
Sales
28
Buy/Sell Ratio
1.00
Total Bought
$0.00
Total Sold
$25.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Apr 06 | BIOGEN INC. | other: See footnotes | Sell | 0 | $0.00 | 0 |
| Fri Mar 13 | Francois Cedric | director, officer: Chief Executive Officer | Sell | 64,869 | $0.00 | 425,968 |
| Tue Mar 03 | Dolsten Mikael | director | Sell | 24,135 | $20.96 | 24,135 |
| Tue Mar 03 | Dolsten Mikael | director: | Sell | 0 | $0.00 | 0 |
| Tue Mar 03 | Dolsten Mikael | director | Sell | 14,312 | $0.00 | 14,312 |
| Fri Feb 13 | DeLong Mark Jeffrey | officer: Chief Business & Strat Officer | Sell | 368 | $22.15 | 114,591 |
| Thu Feb 05 | Francois Cedric | director, officer: Chief Executive Officer | Sell | 8,840 | $3.76 | 490,837 |
| Fri Jan 30 | Chopas James George | officer: VP/Chief Accounting Officer | Sell | 16,150 | $0.00 | 65,955 |
| Fri Jan 30 | Boucher Kelley | officer: Chief People Officer | Sell | 30,146 | $0.00 | 127,804 |